India levodopa market is expected
to grow at a formidable rate during the forecast period. The India Levodopa market
is driven by advancement in diagnosis of Parkinson’s disease progression. Moreover,
development of novel formulations for levodopa is further expected to boost the
demand through FY2026. Continuous demand of Levodopa to treat Parkinson’s
disease is further predicted to increase the product demand in the forthcoming
years, thereby bolstering the market growth.
The India levodopa market is
segmented based on drug type, composition, source, form, distribution channel,
application, end user, company, and region. In terms of composition the market
is fragmented into single and combinational. The combinational drug composition
dominated the market until 2017 and is forecasted to maintain its dominance
during the forecast period as well which can be attributed to certain
advantages such as increased compliance, synergy and high efficacy. In addition
to this, combination drug therapies offer additive benefits that target
multiple pathologic processes, which further contributes to the segmental
growth.
The major players
operating in the India levodopa market are Wockhardt Ltd., Teva Pharmaceuticals
Industries Ltd., Torrent Pharmaceuticals Ltd., Divis Laboratories Ltd., Taj
Pharmaceuticals Ltd., Cipla Ltd., Zydus Cadila Healthcare Ltd. (Neuro), GlaxoSmithKline
Pharmaceuticals Ltd., Nicholas Piramal India Ltd., Micro Labs Ltd. (Synchro)
and others. Major companies are developing advanced technologies, receiving
approvals from regulatory bodies, and launching new products in order to stay competitive in the
market. Other inorganic growth strategies include mergers & acquisitions,
joint ventures, new product developments and pharma licensing in order to
sustain themselves amidst fierce competition.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
Levodopa market from FY2016 to FY2019.
- To estimate and forecast the market size of India
levodopa market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India levodopa market
based on drug type, composition, source, form, distribution channel,
application, end user, company, and regional distribution.
- To identify dominant region or segment in the India
levodopa market.
- To identify drivers and challenges for India levodopa
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
Levodopa market.
- To identify and analyze the profile of leading
players operating in India levodopa market.
- To identify key sustainable strategies adopted
by market players in India levodopa market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India levodopa market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Levodopa manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers.
- Organizations, forums and
alliances related to levodopa.
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India levodopa market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Levodopa Market, By Drug Type:
- Rytary
- Duopa
- Sinemet
- Caramet
- Others
- India Levodopa Market, By Composition:
- India Levodopa Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Levodopa Market, By Form:
- India Levodopa Market, By Distribution Channel:
- India Levodopa Market, By Application:
- Parkinson’s
Disease
- Dopamine
Responsive Dystonia
- Restless
Legs Syndrome (RLS)
- Others
- India Levodopa Market, By End User:
- India Levodopa Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India levodopa market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India levodopa market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]